Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
EJNMMI Research|June 18, 2026
Impact of different PSMA PET-based eligibility criteria on outcome of [177Lu]Lu-PSMA radioligand therapy using [18F]rhPSMA-7/[18F]rhPSMA-7.3 (Flotufolastat)Sonia Grigorascu, Thomas Langbein, Isabel Rauscher, et al.
EJNMMI Research|December 4, 2019
Evaluation of SUV normalized by lean body mass (SUL) in 68Ga-PSMA11 PET/CT: a bi-centric analysisAndrei Gafita, Jeremie Calais, Charlott Franz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2022
177Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical BiomarkersAmir Karimzadeh, Matthias Heck, Robert Tauber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 18, 2025
Impact of baseline 18F-flotufolastat PET bone tumor volume for prognosticating severe hematologic toxicity in patients with metastatic castration-resistant prostate Cancer receiving 177Lu-PSMA-targeted radioligand therapyAmir Karimzadeh, Kimberley Hansen, Stefan Hein, et al.
European Urology|January 24, 2018
Efficacy, Predictive Factors, and Prediction Nomograms for 68Ga-labeled Prostate-specific Membrane Antigen-ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical ProstatectomyIsabel Rauscher, Charlotte Düwel, Bernhard Haller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 30, 2020
A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patientsJan C Peeken, Mohamed A Shouman, Markus Kroenke, et al.
European Urology|December 10, 2021
Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission TomographyValentin H Meissner, Isabel Rauscher, Kristina Schwamborn, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 21, 2026
Value of a repeat 18F-flotufolastat PET scan following a negative scan in patients with suspected biochemical recurrence of prostate cancer after radical prostatectomySonja Kirchhoff, Andreas Lederer, Theo Lorenzini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2022
Validation of 18F-rhPSMA-7 and 18F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate CancerMarkus Kroenke, Lilit Schweiger, Thomas Horn, et al.
Aktuelle Urologie|August 28, 2020
[68Ga-PSMA-11 PET/mpMRI for local detection of primary prostate cancer in men with a negative prior biopsy]Tobias Maurer, Hannah Gesterkamp, Noemi Nguyen, et al.
Pageof 10